SteriMax, Inc.: Ifosfamide Injection new FDA shortage listing (available from this maker)

SteriMax, Inc.: Ifosfamide Injection new FDA shortage listing (available from this maker). Its amount of 1 is below the median of 3 (29th percentile). Dated 57 days ago, it serves as a historical benchmark. Score 65/100. As of 2026-11-04, from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list).

Data as of · Compiled by Zalwin from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)

amount: 1 · 29th percentile of 353 DrugShortagePulse records · 0.3x the median

Free preview: all 12 published fields of this record are shown below. Locked: 352 related DrugShortagePulse records and the 5-column CSV export.

FieldValue
ManufacturerSteriMax, Inc.
DrugIfosfamide Injection
Dosage formInjection
Therapeutic categoryOncology, Pediatric
StatusCurrent
StageNew shortage posted
AvailabilityAvailable
Presentations affected1
Package NDCs21586-211-02
Manufacturer supply noteTo place an order, please contact GlobalRX at [email protected] or (919) 245-8418
First posted2026-06-12
Updated2026-09-08
amount percentile29th of 353 (median 3, 0.3x median)
Peer records CSV (353 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch SteriMax, Inc.

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock SteriMax + all 353 records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Manufacturer · Drug · Stage · Availability · Updated · official source URL

  • Source agency: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)
  • Record date: 2026-09-08
  • Data refreshed: 2026-11-04
  • Refunds on request within 14 days

Search all records free →

Top DrugShortagePulse records: Sanofi-Aventis U.S. LLC · Fresenius Kabi USA, LLC · Hospira, Inc., a Pfizer Company · Fresenius Kabi USA, LLC · Hospira, Inc., a Pfizer Company · Browse all by state and category →

LIVE PUBLIC DATA Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) · Last refreshed: Wed, 04 Nov 2026 06:10:12 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Search, filter and export more DrugShortagePulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

65 / 100 Score

  • Newly posted shortage: buyers are looking for another source now.
  • Sterile injectable: hospital and 503B demand.

What is the DrugShortagePulse record for SteriMax, Inc.?

SteriMax, Inc.'s Ifosfamide Injection is on the FDA drug shortage list. New shortage posted; available from this maker. Last updated 2026-09-08.

How does SteriMax, Inc. compare to other DrugShortagePulse records?

Its amount of 1 is below the median (29th percentile); smaller records often move faster and face less competition. It is 57 days old; check the official source for later updates before acting.

SteriMax, Inc. vs. top 3 peers

OrganizationAmountPercentileRecord date
SteriMax, Inc.129th2026-09-08
Hospira, Inc., a Pfizer Company129th2026-10-21
Fresenius Kabi USA, LLC129th2026-10-15
Hikma Pharmaceuticals USA, Inc.249th2026-10-14

Related records

DrugShortagePulse: New shortage posted DrugShortagePulse: Oncology

How to monitor SteriMax, Inc. and peer oncology records

Get new DrugShortagePulse records like SteriMax, Inc. by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new shortages in your categories

DrugShortagePulse emails new and changed FDA drug shortages matching your therapeutic categories.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.

Often used together